Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Blood (2023) 142 (Supplement 1): 4335.

https://doi.org/10.1182/blood-2023-184432

Published: 2023

Journal Articles

11q Gain with t(11;14) or Alone Were Associated with Poor Prognosis in Newly-Diagnosed Multiple Myeloma Patients By SNP-Array Analysis and FISH

Blood (2023) 142 (Supplement 1): 1968.

https://doi.org/10.1182/blood-2023-184870

Published: 2023

Journal Articles

Helical Tomotherapy and Melphalan As the Conditioning Regimen in Autologous Stem Cell Transplantation for Multiple Myeloma with Extramedullary Plasmacytoma: A Single Center Clinical Research

Pan Liu, Qian Wang, Fuling Zhou

Blood (2023) 142 (Supplement 1): 7075.

https://doi.org/10.1182/blood-2023-188275

Published: 2023

Journal Articles

CNVs Numbers Scoring System Was a Good Prognostic Risk Stratification for NDMM with Whole Genomic Mapping Array

Zhao Zeng, Chengcheng Fu, Jinlan Pan, Jiao Lu, Jingjing Shang, Zhiyu Zhang, Hongying You, Wanhui Yan, Chunxiao Wu, Qinrong Wang, Qian Wang, Lijun Wen, Song Jin, Lingzhi Yan, Suning Chen, De-pei Wu

Blood (2023) 142 (Supplement 1): 4725.

https://doi.org/10.1182/blood-2023-184504

Published: 2023

Journal Articles

Mesenchymal Stromal Cell-Derived MMP14 Facilitates Leukemia Progression and Chemotherapy Resistance

Jinxian Wu, Xiaoyan Liu, Xinqi Li, Qian Wang, Nan Zhang, Fuling Zhou

Blood (2023) 142 (Supplement 1): 5993.

https://doi.org/10.1182/blood-2023-182746

Published: 2023

Journal Articles

Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Yan Yuan, Qian Wang, Dongxiao Zhuang, Tianling Ding, Hong Chen, Fengping Zhu, Kang Zheng, Rui Feng, Jiajun Zheng, Xiaoluo Zhang, Zunguo Du, Ping Zhu, Jinsong Wu, Ying Mao, Tong Chen

Blood (2023) 142 (Supplement 1): 6225.

https://doi.org/10.1182/blood-2023-181427

Published: 2023

Journal Articles

Demethylation Strategies for the Treatment of Acute Myeloid Leukemia: Targeting Protacs That Degrade DNA Methyltransferase

Nan Zhang, Lilan Xin, Qian Wang, Guopeng Chen, Linlu Ma, Yuxing Liang, Fuling Zhou

Blood (2023) 142 (Supplement 1): 5963.

https://doi.org/10.1182/blood-2023-174190

Published: 2023

Journal Articles

Development of a Risk Assessment Model for Cardiac Injury in Patients Newly Diagnosed with Acute Myeloid Leukemia Based on a Multicenter, Real-World Analysis in China

Linlu Ma, Qian Wang, Xinqi Li, Nan Zhang, Yuxing Liang, Jinxian Wu, Guolin Yuan, Fuling Zhou

Blood (2023) 142 (Supplement 1): 5855.

https://doi.org/10.1182/blood-2023-174050

Published: 2023

Journal Articles

The Impact of Chimeric Antigen Receptor T Cell Quality to Clinical Safety and Efficacy in Non-Hodgkin Lymphomas

Qian Wang, Liqing Kang, Yishan Duan, Mao Jin, Ying Zhu, Mengya Cong, Xin Xiang, Xiao Ma, Lei Yu, Depei Wu, Haiwen Huang

Blood (2022) 140 (Supplement 1): 6676–6677.

https://doi.org/10.1182/blood-2022-165184

Published: 2022

Journal Articles

Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Yan Yuan, Qian Wang, Dongxiao Zhuang, Tianling Ding, Hong Chen, Fengping Zhu, Kang Zheng, Rui Feng, Jiajun Zheng, Xiaoluo Zhang, Zunguo Du, Ping Zhu, Jinsong Wu, Ying Mao, Tong Chen

Blood (2022) 140 (Supplement 1): 6629–6630.

https://doi.org/10.1182/blood-2022-159309

Published: 2022

Journal Articles

Reactive Oxygen Species-Mediated c-Jun Activation Domain-Binding Protein-1 (Jab1) Promotes Immune Escape in Hyperleukocytic Acute Myeloid Leukemia

Nan Zhang, Qian Wang, Xinqi Li, Yuxing Liang, Fuling Zhou

Blood (2022) 140 (Supplement 1): 11489.

https://doi.org/10.1182/blood-2022-157261

Published: 2022

Journal Articles

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Qian Wang, Haiping Dai, Wenzhi CAI, Qinrong Wang, Zhu Mingqing, Lingzhi Yan, Yan Yu, Hongjie Shen, Yang Xu, Ying Wang, Miao Miao, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Jinyan Huang, Depei Wu, Suning Chen

Blood (2022) 140 (Supplement 1): 9198–9200.

https://doi.org/10.1182/blood-2022-156862

Published: 2022

Journal Articles

Trial in Progress: A Phase 4 Multicenter Study of Brentuximab Vedotin Treatment in Chinese Patients with CD30-Positive Cutaneous T-Cell Lymphoma

Qian Wang, Ming Jiang, Chunlei Zhang, Sheng Wu, Wenhan Jiang, Meng Ji, Tong Chen

Blood (2022) 140 (Supplement 1): 12044–12045.

https://doi.org/10.1182/blood-2022-166617

Published: 2022

Journal Articles

Anti CD19 CART Therapy Following Allogenic Hematopoietic Stem Cell Transplantation Improved the Survival of Patients with BCR::ABL1 -like Acute Lymphoblastic Leukemia

Haiping Dai, Wei Cui, Hongjie Shen, Qian Wang, Jia Yin, Zheng Li, Depei Wu, Xiaowen Tang

Blood (2022) 140 (Supplement 1): 10345–10346.

https://doi.org/10.1182/blood-2022-166687

Published: 2022

Journal Articles

Mutational Profiles during the Progression of Chronic Myeloid Leukemia

Mengxing Xue, Zhao Zeng, Qinrong Wang, Lijun Wen, Yi Xu, Jundan Xie, Qian Wang, Changgeng Ruan, Depei Wu, Suning Chen

Blood (2021) 138 (Supplement 1): 3596.

https://doi.org/10.1182/blood-2021-154273

Published: 2021

Journal Articles

Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) at Admission Are Predictors for Worse Functional Outcome in Cerebral Venous Sinus Thrombosis

Binbin Zheng, MDMSc, Qian Wang, MD MPH, Sridevi Rajeeve, MD, Biyue Dai, PhD, Cynthia Zevallos, MD, Darko Quispe-Orozco, MD, Mudassir Farooqui, MDMPH, Jorge Ares-Morcuende, Santiago Ortega-Gutierrez, MDMSc

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138963

Published: 2020

Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD

Blood (2019) 134 (Supplement_1): 5647.

https://doi.org/10.1182/blood-2019-125275

Published: 2019

Journal Articles

The Role of CD39/CD73/Ado/A2AR Axis and HIF-1α in Chronic Lymphocytic Leukemia

Yiqing Cai, Lili Feng, MD PhD, Dai Yuan, MD, Qian Wang, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 4406.

https://doi.org/10.1182/blood-2018-99-115732

Published: 2018

Journal Articles

Cardiovascular Mortality Among CML Patients in the Pre-TKI and TKI Eras: A SEER Analysis 1992-2004

Qian Wang, MD MPH, Yaning Zhang, MD, Bing Yue, MD, Yu Zhang, MD, Changchuan Jiang, MDMPH, Stuthi Perimbeti, MD MPH, Michael J. Mauro, MD

Blood (2018) 132 (Supplement 1): 1737.

https://doi.org/10.1182/blood-2018-99-110408

Published: 2018

Journal Articles

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Stuthi Pavani Perimbeti, MD MPH, Kevin Ye Hou, MD, Sabarina Ramanathan, MD, Adonas Woodard, MD, Daniel Kyung, MD, Qian Wang, MD MPH, Pamela Ann Crilley, DO, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5886.

https://doi.org/10.1182/blood-2018-99-119961

Published: 2018

NARROW

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

11q Gain with t(11;14) or Alone Were Associated with Poor Prognosis in Newly-Diagnosed Multiple Myeloma Patients By SNP-Array Analysis and FISH

Helical Tomotherapy and Melphalan As the Conditioning Regimen in Autologous Stem Cell Transplantation for Multiple Myeloma with Extramedullary Plasmacytoma: A Single Center Clinical Research

CNVs Numbers Scoring System Was a Good Prognostic Risk Stratification for NDMM with Whole Genomic Mapping Array

Mesenchymal Stromal Cell-Derived MMP14 Facilitates Leukemia Progression and Chemotherapy Resistance

Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Demethylation Strategies for the Treatment of Acute Myeloid Leukemia: Targeting Protacs That Degrade DNA Methyltransferase

Development of a Risk Assessment Model for Cardiac Injury in Patients Newly Diagnosed with Acute Myeloid Leukemia Based on a Multicenter, Real-World Analysis in China

The Impact of Chimeric Antigen Receptor T Cell Quality to Clinical Safety and Efficacy in Non-Hodgkin Lymphomas

Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Reactive Oxygen Species-Mediated c-Jun Activation Domain-Binding Protein-1 (Jab1) Promotes Immune Escape in Hyperleukocytic Acute Myeloid Leukemia

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Trial in Progress: A Phase 4 Multicenter Study of Brentuximab Vedotin Treatment in Chinese Patients with CD30-Positive Cutaneous T-Cell Lymphoma

Anti CD19 CART Therapy Following Allogenic Hematopoietic Stem Cell Transplantation Improved the Survival of Patients with BCR::ABL1 -like Acute Lymphoblastic Leukemia

Mutational Profiles during the Progression of Chronic Myeloid Leukemia

Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) at Admission Are Predictors for Worse Functional Outcome in Cerebral Venous Sinus Thrombosis

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

The Role of CD39/CD73/Ado/A2AR Axis and HIF-1α in Chronic Lymphocytic Leukemia

Cardiovascular Mortality Among CML Patients in the Pre-TKI and TKI Eras: A SEER Analysis 1992-2004

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only